Genetic medicine:- Is This The Future Treatment of Neuro-Oncology?

Genetic medication is the joining and utilization of genomic innovations permits biomedical scientists and clinicians to gather information from enormous investigation populace and to get infection and genetic bases of medication reaction. It incorporates genome structure, useful genomics, epigenomics, genome scale populace genomics, frameworks examination, pharmacogenomics and proteomics.

Most Common Genetic Disorders:

  • Down syndrome
  • Thalassemia.
  • Cystic Fibrosis.
  • Tay-Sachs disease.
  • Sickle Cell Anaemia

  • Down syndrome
  • Thalassemia
  • Cystic Fibrosis
  • Tay-Sachs disease
  • Sickle Cell Anaemia

Related Conference of Genetic medicine:- Is This The Future Treatment of Neuro-Oncology?

June 29-30, 2026

37th Conference on Clinical Neuroscience and Neurogenetics

Aix-en-Provence, France
June 29-30, 2026

39th European Neurology Congress

London, UK
July 20-21, 2026

37th World Congress on Neurology and Neuroscience

Amsterdam, Netherlands
July 23-24, 2026

14th International Conference on Cannabis & Medicinal Research

Amsterdam, Netherlands
September 18-19, 2026

21st Annual Congress on Neuroscience

Dubai, UAE
November 16-17, 2026

8th World Brain Congress

Tokyo, Japan
November 23-24, 2026

16th Global Alzheimers Summit

Paris, France
December 21-22, 2026

6th International Conference on Child Neurology

Paris, France
March 22-23, 2027

8th International Conference on Neurologists

Singapore City, Singapore

Genetic medicine:- Is This The Future Treatment of Neuro-Oncology? Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in